|
Harbert Venture Partners provides growth capital to early stage information technology and healthcare companies primarily across the Southeastern U.S. We seek to capitalize on what we believe are compelling regional dynamics, such as a strong and fast-growing economy, significant research and development activities, an established entrepreneurial community and a relative lack of residential institutional venture capital, that make the Southeastern U.S. more attractive than other traditional United States venture capital markets. With offices in Birmingham, Alabama, Richmond, Virginia and Gainesville, Florida, we are well positioned to identify attractive opportunities throughout the Southeast. Harbert Venture Partners, LLC (HVP I) held its final closing in December 2004 and has invested in thirteen early growth stage IT and healthcare companies across the Southeastern U.S. markets. Harbert Venture Partners II, L.P. (HVP II) held its final closing in October 2009 and has invested in eleven early growth stage IT and healthcare companies. We seek board representation and teams with high quality syndicate partners in our portfolio companies. We are actively engaged in providing constructive strategic and operating guidance to our portfolio company CEOs, with particular focus on recruitment of seasoned management teams, establishment and performance of milestones and efficient deployment of capital. In total Harbert Venture Partners has over $150 million in committed capital and continues to evaluate new opportunities within its established criteria. Investment Team- William W. Brooke, Managing Partner
- Wayne L. Hunter, Managing Partner
- Thomas D. Roberts III, Partner
- Robert L. Crutchfield, Venture Partner
- Brian C. Carney, Principal
- Thomas I. Walton-Cale, Senior Analyst
| Investment CriteriaHVP seeks to identify and invest in emerging portfolio companies with high growth potential at valuations which reflect a realistic view of exit opportunities. We seek to invest with seasoned entrepreneurs building early stage growth companies with defensible positions in large and growing markets. We typically invest in the first or second institutional rounds, with initial investment amounts between $1.0 and $4.0 million. We typically seek board representation in our investments and endeavor to provide constructive, strategic, operating and networking support to our portfolio companies. | We concentrate our investment focus on opportunities that, in our view, demonstrate the following characteristics: - Experienced management teams
- Large addressable markets
- Recurring revenue business models
- Scalable operating platforms
- Attractive exit possibilities
Particular sectors of investment interest include: Information Technology - Software
- Communications
- Digital media
- Security
- Financial technology
- Energy IT
Healthcare - Medical devices/technology
- Healthcare IT
- Healthcare services
- Diagnostics
- Life Sciences
| |
Important Notices:- This site is designed to provide basic information about our alternative investment strategies. Nothing on the site is a recommendation that you purchase, sell or hold any security or other investment, or that you pursue any investment style or strategy.
- The password-protected portion of the site is designed for individuals and institutions that are “qualified purchasers” and “accredited investors.” Only such individuals and institutions may access the information on this password-protected site. All individuals and institutions requesting access will be screened to determine eligibility.
|
